Sickle Cell Disease Symposium set for Sept. 27
![A 3D animation of Sickle Cell Disease](https://med.uth.edu/wp-content/uploads/2024/09/Sickle-Cell-Disease-Animation.jpg)
The UTHealth Houston Center for Clinical and Translational Sciences will host the Sickle Cell Disease Symposium from 8 a.m. until 5 p.m., Sept. 27, at the Memorial Hermann Hospital – Texas Medical Center.
The Sickle Cell Disease Symposium brings experts in the field and individuals living with sickle cell disease together to improve awareness, treatment, and management of the disease. The symposium will feature presentations, panel discussions, and a keynote address from Rep. Jarvis Johnson of the Texas House of Representatives.
Speakers for the event from McGovern Medical School include Modupe Idowu, MD, professor in the Department of Internal Medicine, and Tolulope Oso, MD, assistant professor in the Department of Anesthesiology, Critical Care, and Pain Medicine. Idowu will discuss emerging sickle cell disease therapies, while Oso will present on pain management for sickle cell disease. The conference will also feature speakers from The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital as well as a trio of panel discussions.
According to the National Institutes of Health, sickle cell disease – also called sickle cell anemia – is a group of disorders that affect hemoglobin, and causes blood cells to be misshaped, typically crescent- or “sickle”–shaped, making them move less easily which can lead to blocking blood flow for the body. The disease affects more than 100,000 people in the United States and 8 million people worldwide.
The free event will be held in the Memorial Hermann Conference Center located on the Ground Floor, Atrium at Memorial Hermann Hospital – Texas Medical Center (6411 Fannin St.). Additionally, a virtual format of the symposium will be available online. For more information and to register for the event, click here.